QNCX Regains $1.00 Bid Price Compliance, 10-Day Streak, Nasdaq Notice; Still Faces $50M MVLS Challenge Until Sept 2026
Quince Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.15
+8.1% in 3d after detection
Post-detection moves
1h
—
1d
0.0%
3d
+8.1%
7d
+5.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS